In general, the results of all these studies suggest that miR-33 contributes to the development of atherosclerosis in mammals by affecting many processes, including the reduction of ABCA1 expression, which decreases the RCT rate, at least under certain conditions. The gene discussed is ABCA1; the disease is atherosclerosis.